Found: 7
Select item for more details and to access through your institution.
Detection of pre-existing neutralizing antibodies against Ad26 in HIV-1-infected individuals not responding to the Ad26.COV2.S vaccine.
- Published in:
- Infection, 2023, v. 51, n. 6, p. 1657, doi. 10.1007/s15010-023-02035-6
- By:
- Publication type:
- Article
Successful direct acting antiviral (DAA) treatment of HCV/HIV-coinfected patients before and after liver transplantation.
- Published in:
- PLoS ONE, 2018, v. 13, n. 6, p. 1, doi. 10.1371/journal.pone.0197544
- By:
- Publication type:
- Article
Ex Vivo Blockade of the PD-1 Pathway Improves Recall IFNγ Responses of HIV-Infected Persons on Antiretroviral Therapy.
- Published in:
- Vaccines, 2023, v. 11, n. 2, p. 211, doi. 10.3390/vaccines11020211
- By:
- Publication type:
- Article
Recognition of the Highly Conserved YMDD Region in the Human Immunodeficiency Virus Type 1 Reverse Transcriptase by HLA-A2-Restricted Cytotoxic T Lymphocytes from an Asymptomatic Long-Term Nonprogressor.
- Published in:
- Journal of Infectious Diseases, 1996, v. 173, n. 2, p. 476
- By:
- Publication type:
- Article
SARS-CoV-2-Seronegative Subjects Target CTL Epitopes in the SARS-CoV-2 Nucleoprotein Cross-Reactive to Common Cold Coronaviruses.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2021.627568
- By:
- Publication type:
- Article
Definition of a New HLA B*52-Restricted Rev CTL Epitope Targeted by an HIV-1-Infected Controller.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 2, p. 567, doi. 10.3390/v15020567
- By:
- Publication type:
- Article
Characterization of Serum and Mucosal SARS-CoV-2-Antibodies in HIV-1-Infected Subjects after BNT162b2 mRNA Vaccination or SARS-CoV-2 Infection.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 3, p. 651, doi. 10.3390/v14030651
- By:
- Publication type:
- Article